Cargando…
A dose-ranging, parallel group, split-face, single-blind phase II study of light emitting diode-red light (LED-RL) for skin scarring prevention: study protocol for a randomized controlled trial
BACKGROUND: Skin fibrosis is a significant global health problem that affects over 100 million people annually and has a profoundly negative impact on quality of life. Characterized by excessive fibroblast proliferation and collagen deposition, skin fibrosis underlies a wide spectrum of dermatologic...
Autores principales: | Nguyen, Julie K., Weedon, Jeremy, Jakus, Jeannette, Heilman, Edward, Isseroff, R. Rivkah, Siegel, Daniel M., Jagdeo, Jared R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631489/ https://www.ncbi.nlm.nih.gov/pubmed/31307501 http://dx.doi.org/10.1186/s13063-019-3546-6 |
Ejemplares similares
-
A single-blind, dose escalation, phase I study of high-fluence light-emitting diode-red light (LED-RL) on human skin: study protocol for a randomized controlled trial
por: Ho, Derek, et al.
Publicado: (2016) -
Resveratrol Prevents High Fluence Red Light-Emitting Diode Reactive Oxygen Species-Mediated Photoinhibition of Human Skin Fibroblast Migration
por: Mamalis, Andrew, et al.
Publicado: (2015) -
Visible Red Light Emitting Diode Photobiomodulation for Skin Fibrosis: Key Molecular Pathways
por: Mamalis, Andrew, et al.
Publicado: (2016) -
A single-blind, dose-escalation, phase I study of high-fluence light-emitting diode-red light on Caucasian non-Hispanic skin: study protocol for a randomized controlled trial
por: Wang, Erica B., et al.
Publicado: (2019) -
Light‐emitting diodes in dermatology: A systematic review of randomized controlled trials
por: Jagdeo, Jared, et al.
Publicado: (2018)